Ceptaris Therapeutics' Grant - V Round

Ceptaris Therapeutics raised a round of funding on March 13, 2009. Investors include Qualifying Therapeutic Discovery Project.

Ceptaris Therapeutics, formerly Yaupon Therapeutics, is developing a gel formulation of mechlorethamine hydrochloride (mechlorethamine) for the treatment of early stage (stages I-IIA) mycosis fungoide…

Articles about Ceptaris Therapeutics' Grant - V Round: